Wegovy savings card: how to get the $25 coupon, and every other way to pay less in 2026

How do you get the $25 Wegovy savings card?

There is no paper coupon to hunt down and no income form to fill in. The card is a digital offer from Novo Nordisk, and getting it takes a few minutes. What decides whether it works for you is your insurance type, not your dose or how long you've been on Wegovy.

• Check you're eligible: you need commercial insurance (employer plan, marketplace plan, or a private plan you buy yourself). Federal and state employee plans and ACA marketplace plans count as commercial. Medicare, Medicaid, TRICARE, VA and other government coverage do not.
• Activate it: text SAVE to 83757, or fill in the short eligibility form on NovoCare. You get a card with a BIN, PCN, group and member ID, exactly like a secondary insurance card.
• Hand it to the pharmacy: give those numbers to your pharmacist (or add them to your online pharmacy profile). They run your insurance first, then the card, and your copay drops to as little as $25. If you fill through NovoCare Pharmacy, you don't even need the card — the discount is applied automatically.
• Reuse it every fill: the same card stays on your pharmacy profile from one refill to the next, including when your prescriber moves you up a dose.

Does the Wegovy coupon work on every dose, including 1.7 mg and the pill?

Yes. The offer is dose-independent: it applies to every Wegovy pen strength, from the 0.25 mg starter through 0.5, 1, 1.7 and 2.4 mg, and to the newer 7.2 mg HD pen. It also covers the Wegovy tablet at all four strengths (1.5, 4, 9 and 25 mg). Novo defines a month as one box of four pens or one bottle of 30 tablets, and the same $25 applies to either.

That matters for the 1.7 mg question specifically, because it's the dose a lot of women settle on as maintenance and the one people most often search a separate coupon for. There isn't one, and you don't need one — the card you activated at 0.25 mg carries straight through. If your pharmacy quotes a different price at 1.7 mg than at 1 mg, the card wasn't re-applied to the new NDC, so ask them to run it again.

How much does the card actually save, and what if your plan doesn't cover Wegovy?

The $25 is a floor, not a guarantee. Novo Nordisk pays up to $100 per one-month fill ($200 for a two-month, $300 for a three-month). So if your plan's copay for Wegovy is $125 or less, you pay $25. If your copay is $200, the card takes off $100 and you pay $100. If you have a high deductible you haven't met yet, the card only shaves $100 off whatever your plan charges you that month, which can still leave a large bill until the deductible is satisfied.

If your commercial plan excludes Wegovy entirely, there's nothing for the card to attach to — a savings card reduces a copay, it can't create coverage. Novo's answer for that situation is now the same as for uninsured patients: its self-pay pricing, which we cover below. Government-insured patients can also use that cash pricing, as long as the claim is run outside their insurance.

Getting Wegovy covered by insurance: where to start

The savings card is only worth $25 if your insurance covers Wegovy at all. Many plans do, and more added coverage through 2025 and 2026 as the cardiovascular evidence for semaglutide (the SELECT trial) became harder to ignore. But coverage still varies enormously by plan, employer, and whether an obesity-treatment benefit was added on purpose.

• Check your plan's formulary: look for semaglutide or Wegovy under 'weight management' or 'obesity treatment', not just the general drug list.
• BMI and comorbidity criteria: most plans require a BMI of 30 or higher, or 27 or higher with at least one comorbidity (hypertension, high cholesterol, type 2 diabetes, sleep apnea, or cardiovascular disease).
• Prior authorization is almost always required: your prescriber submits documentation of BMI, comorbidities, and often prior attempts at lifestyle modification.
• If denied: appeal with a physician letter citing clinical necessity and the SELECT trial data for cardiovascular benefit. Many denials reverse on the first appeal.
• Employer-sponsored plans: some large self-insured employers added GLP-1 obesity coverage in 2025–2026 even if their prior plans didn't include it — worth confirming with HR.

NovoCare self-pay: Wegovy from $149 a month with no insurance

For women whose plan won't cover Wegovy, or who have no insurance at all, Novo Nordisk's self-pay program is the cheapest brand-name route, and it now has two formats. The Wegovy pill costs $149 a month at the 1.5 mg starting dose, $199 at 4 mg, and $299 at the 9 mg and 25 mg maintenance doses. The pen is $199 a month for your first two fills as a new patient (an offer that runs through December 31, 2026), then $349 a month at the standard 0.25 to 2.4 mg doses or $399 at the 7.2 mg HD strength.

You can have either shipped from NovoCare Pharmacy or, once you've enrolled, pick it up at a retail pharmacy at the same price. It's FDA-approved Wegovy in both cases. Note that the pill and pen price ladders climb with the dose, so budget for the maintenance figure rather than the starting one.

GoodRx coupons: they now mirror Novo's cash price

A year ago GoodRx ran its own Wegovy coupon that landed somewhere between $300 and $500 a month. That's gone. Since the Wegovy pill launched, GoodRx has instead surfaced Novo Nordisk's own self-pay price at more than 70,000 pharmacies: $149 to $299 for the pill depending on dose, and $199 for the first two pen fills then $349 to $399. So GoodRx won't beat NovoCare, but it's a convenient way to get the same price at your usual CVS, Walgreens or Costco without setting up a NovoCare Pharmacy shipment.

Two things it can't do: it can't be combined with insurance or the $25 savings card, and a plain GoodRx retail coupon on Wegovy (without the manufacturer partnership) still lands near list price. Make sure the quote you're looking at says it's the Novo Nordisk cash price.

Medicare and Wegovy: the $50 GLP-1 Bridge

Medicare has long excluded weight-loss drugs from Part D, which is also why the $25 savings card can't be used with Medicare. That changed on July 1, 2026, when CMS launched the Medicare GLP-1 Bridge: eligible Part D and Medicare Advantage members can get any dose of Wegovy, pen or pill, for a flat $50 a month through December 31, 2027. The $50 doesn't count toward your Part D deductible or out-of-pocket cap, and it's the same price at every stage of the benefit.

• Who qualifies: adults 18 and over with a BMI of 35 or higher; or a BMI of 30 or higher with heart failure, uncontrolled high blood pressure, or stage 3a+ chronic kidney disease; or a BMI of 27 or higher with a history of prediabetes, heart attack, stroke, or peripheral artery disease.
• Which plans: a standalone Part D plan or a Medicare Advantage coordinated-care plan (HMO, HMO-POS, local or regional PPO) with drug coverage. Your plan and prescriber handle the enrollment; you don't apply directly to CMS.
• Already covered for heart disease? Wegovy has been on some Part D formularies since 2024 for people with established cardiovascular disease. If that's you, compare your plan's regular copay with the flat $50 Bridge price and use whichever is lower.

What doesn't exist: free trials and patient assistance

Wegovy has no patient assistance program for uninsured, low-income patients, and no free-trial or sample program. Novo Nordisk has been criticized for that gap given the population that most needs the drug. In practice the self-pay pill at $149 a month is now the lowest official channel, and for women who can't manage that, compounded semaglutide through a telehealth provider is the only substantially cheaper alternative.